Parallel imports of pharmaceutical products in the European Union
By: Mattias Ganslandt and Keith E. Maskus.
Contributors: Maskus, Keith E.; World Bank. Development Research Group. Trade.
Series: Policy research working paper ;; 2630; Policy research working papers (Online) ;; 2629.
Publisher: World Bank, Development Research Group, Trade
Published: 2001
Place of publication: Washington, D.C
Language: eng
Format: Electronic resource
Subjects: Drugs -- Prices -- European Union countries -- Econometric models.; Gray market -- European Union countries -- Econometric models.; Price regulation -- European Union countries -- Econometric models.; Trademarks (International law) -- Econometric models.; Imports -- European Union countries -- Econometric models.
Genres: Econometric models.
Description: Parallel imports are legitimately produced goods imported legally into a country without the authorization of a trademark, copyright, or patent holder. In the European Union, so long as a pharmaceutical manufacturer has placed a good on the market voluntarily, the principle of free movement of goods allows individuals or firms within the EU to trade goods across borders without the consent of the producer. What is the effect of these parallel imports?
Notes: Includes bibliographical references (p. 22).
Title from title screen as viewed on Sept. 07, 2002.
"July 2001."
Also available in print.
Mode of access: World Wide Web.